Yann Neuzillet
Suresnes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 220 publications
Shifting Risk Profile in Radical Prostatectomy Over 18 Years: A Bicentric French Study of 8,358 Patients.
Journal: The French journal of urology
Published: May 02, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG.
Journal: The French journal of urology
Published: April 01, 2026
Multicentre Validation of the 2019 Briganti Nomogram: One Threshold Does Not Fit All.
Journal: International braz j urol : official journal of the Brazilian Society of Urology
Published: March 17, 2026
Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBC.
Journal: The French journal of urology
Published: March 16, 2026
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.
Journal: European urology oncology
Published: December 18, 2025
Updated 2025 French guidelines for renal cell carcinoma.
Journal: The French journal of urology
Published: October 10, 2025
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025.
Journal: The French journal of urology
Published: October 09, 2025
French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes.
Journal: The French journal of urology
Published: October 06, 2025
Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy.
Journal: World journal of urology
Published: October 05, 2025
Paleoproteomic study of blood residues shows that Voltaire (1778) died of perforated bladder squamous cell cancer with peritoneal extension.
Journal: BJU international
Published: September 22, 2025
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
Last Updated: 09/26/2026